Barriers to primary care physicians prescribing buprenorphine. - Wikidata - wikimedia - TriplyDB

Barriers to primary care physicians prescribing buprenorphine.

Barriers to primary care physicians prescribing buprenorphine.

http://www.wikidata.org/entity/Q37628725

about

Update on Barriers to Pharmacotherapy for Opioid Use Disorders.A review of a national training initiative to increase provider use of MAT to address the opioid epidemic.Geographic and specialty distribution of US physicians trained to treat opioid use disorder.Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care.Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process Access to Addiction Pharmacotherapy in Private Health Plans.Buprenorphine Prescribing Availability in a Sample of Ohio Specialty Treatment Organizations Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11 Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.Optimizing psychosocial support during office-based buprenorphine treatment in primary care: Patients' experiences and preferences.Primary care for opioid use disorder.Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies.Enhancing transitions from addiction treatment to primary care.The Time is Now: Improving Substance Abuse Training in Medical Schools.Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.Medication-Assisted Opioid Treatment Prescribers in Federally Qualified Health Centers: Capacity Lags in Rural Areas.Text message reminders for improving patient appointment adherence in an office-based buprenorphine program: A feasibility study.Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System.Integration of Care in the Implementation of the Affordable Care Act: Changes in Treatment Services in a National Sample of Centers Treating Substance Use Disorders.Assessing Differences in the Availability of Opioid Addiction Therapy Options: Rural Versus Urban and American Indian Reservation Versus Nonreservation.The Availability of Ancillary Counseling in the Practices of Physicians Prescribing Buprenorphine.Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City.Why aren't physicians prescribing more buprenorphine?Addressing substance use disorder in primary care: The role, integration, and impact of recovery coaches.Opioid analgesics and chronic non-cancer pain: a prescription for research in primary care.Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.In This Issue: Building Blocks for Improving Practice.Now is the Time to Address Substance Use Disorders in Primary Care.Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in Ohio.Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers.Text message content preferences to improve buprenorphine maintenance treatment in primary care.Buprenorphine Provision by Early Career Family Physicians Emerging Evidence for Cannabis' Role in Opioid Use Disorder

P2860

Q30234408-C1A02239-2A67-41DB-97EC-B9D2D0514979 Q30239840-5996DD82-CAB1-414E-837C-76E479A2D3A7 Q34920940-8ACD1F67-6951-40C6-A95D-AD0A1D7BA32B Q35400440-926174BB-67CD-4D2A-B285-5356E8D12B7D Q35734945-E4022B9A-8F00-49D3-9A54-B1137FB823A7 Q35752218-B4FADC3A-0A8B-4495-A3B6-87B5F75671EF Q36025907-F69C59EA-906D-494C-A8A1-E18B4001CC21 Q36058075-6953AFE2-0FF9-43D3-8F50-BF96FECB32CE Q36118052-C03AD503-CA83-459F-8075-1C65093613C5 Q36367544-1C87D36C-73C0-4264-88A5-C7144533E0F4 Q36549928-137DB477-29D2-4631-B545-3E57AFE4AC3F Q36619638-E11A32AD-FD23-4A52-86D1-0C92E6A05F5F Q36711972-84DB4354-C452-4977-9A29-7D26125D7568 Q37194326-E4111956-568B-4FE7-A41D-FD854EE08370 Q37673456-0672F1AC-6690-426E-86D2-763874809E7F Q38244651-F75E9DDE-3AC7-4BC2-878C-DAD22E767189 Q38258422-0E58C212-9A85-4C70-9356-C79B51217F34 Q38370171-4F5A4003-3957-45EA-94B3-AADB517B598B Q38374123-541FAC92-2E39-4D43-8AD5-289C54C641EC Q38607465-49FCE818-D278-45C4-A1F4-F7882EF6CE3D Q38643890-6C54BAAB-CFA6-4D5D-9A2E-57F84E09E367 Q38828787-483B595C-AA20-4998-9EA2-DDEE61CF55E2 Q38871371-39979C53-7A96-4AD6-843F-AA51E1FC6AC0 Q39912008-32D64AEA-76D3-44CA-8D38-8BC916717AE9 Q40396333-B7391FD1-55D3-476B-BF3F-044A9584074A Q41209394-9397B7AB-4FEC-40EB-8AD9-830A032BB475 Q42024652-8EA88C02-4A18-45A6-B35D-9F2D26DB4D79 Q42695820-89BFE85D-1763-4175-B0EC-0780B66318F4 Q44339217-73DA71B3-CB2E-4BE1-96EB-847B49C46DB8 Q44347160-4F3DEB10-EF53-42DE-9922-94783075CF44 Q44350939-261E1BF6-97E4-416C-88DB-5D3B39901EE2 Q46015888-E91475C5-52DB-4343-BEE0-9D796BF0DC49 Q47162534-4D69BDEE-35A8-4F84-A5BB-E7990E7E85DF Q47412301-2EDCAA10-063D-493D-8967-0948DA99D0F9 Q47693045-58ABDCB9-34C6-4907-AD64-6D77FA4DD613 Q50253990-F14CDC7C-5FCF-4BD7-9C8D-9C486B31E2C4 Q57100264-3C4EC243-85FE-499D-B53E-D152FB8C6E0F Q58775143-BCD6771B-F9D4-4564-8403-C4DD96129D63

P2860

Barriers to primary care physicians prescribing buprenorphine.

http://www.wikidata.org/entity/Q37628725

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Barriers to primary care physicians prescribing buprenorphine.

@en

Barriers to primary care physicians prescribing buprenorphine.

@nl

type

label

Barriers to primary care physicians prescribing buprenorphine.

@en

Barriers to primary care physicians prescribing buprenorphine.

@nl

prefLabel

Barriers to primary care physicians prescribing buprenorphine.

@en

Barriers to primary care physicians prescribing buprenorphine.

@nl

P1433

Q37628725-A835A8B4-3CC5-4377-8C62-517013F547A1

P1476

Q37628725-3E9D2A96-897B-4123-A7C1-406404D66A13

P2093

Q37628725-52F255D1-9259-413A-8F38-975C56299892

Q37628725-69429838-629A-43A9-981E-CCFB0982E3DE

Q37628725-B83BC65E-594C-4630-BED0-25505E113D0B

Q37628725-C285A9A8-D454-4787-B7C4-7B407C4EED5F

Q37628725-E8BBB4E9-1BB0-4422-AA2D-619EB6E5FCB1

P2860

Q37628725-00837D6E-DDD6-4A16-8A41-04F91A44B31D

Q37628725-1336D06F-059B-4C35-ACB5-2183077C352E

Q37628725-204EA6E2-A9D9-460D-8B48-675DC1E3C3FC

Q37628725-2A43064C-4929-472A-B4AF-129AB7D398D2

Q37628725-30D5B5A8-9169-44DE-BF5A-AC97B2DEDA70

Q37628725-4A0BC5E2-A77E-4048-847E-46BADB9E14EC

Q37628725-68BAD4A5-5CE8-4E9D-9334-5FCAA36C43DE

Q37628725-69974E39-9ADC-47C8-8FF8-3698C36DA07E

Q37628725-6A701003-6BDA-470D-A576-175D20ADE01D

Q37628725-6C39352A-0684-466E-80B3-B584BE05076F

P304

Q37628725-0E5866E5-12EC-4858-AD4E-F260DF43FA8D

P31

Q37628725-966A6B1B-4B6F-4B6D-A61A-6938F5B9468C

P356

Q37628725-0CE835A0-CAB2-42AD-851E-380DE472C11A

P407

Q37628725-4BEAC93B-04B9-4897-A290-F4CEB39C2A73

P433

Q37628725-1D508349-8ABB-496C-84C1-9669591D737E

P478

Q37628725-D25FB189-6CC5-4C7C-89E5-F83F0F1832F9

P577

Q37628725-CAC9CCB2-0F34-429D-A207-D9885A29AEFE

P5875

Q37628725-E42A540C-D23B-4477-9CCD-6B5F6FDEC646

P698

Q37628725-310CE4D3-5645-4C93-A780-C559A22F835A

P932

Q37628725-5F173743-9436-428D-B5C9-73865D99C5E3

P356

P1433

Annals of Family Medicine

P1476

Barriers to primary care physicians prescribing buprenorphine.

@en

P2093

C Holly A Andrilla

http://www.w3.org/2001/XMLSchema#string

Eliza Hutchinson

http://www.w3.org/2001/XMLSchema#string

Laura-Mae Baldwin

http://www.w3.org/2001/XMLSchema#string

Mary Catlin

http://www.w3.org/2001/XMLSchema#string

Roger A Rosenblatt

http://www.w3.org/2001/XMLSchema#string

P2860

Factors affecting willingness to provide buprenorphine treatment.

Integrating buprenorphine treatment into office-based practice: a qualitative study

Clinical practice. Office-based treatment of opioid-dependent patients.

Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.

Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adopters

Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians

Just call it "treatment".

Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care.

State policy influence on the early diffusion of buprenorphine in community treatment programs

Office-based management of opioid dependence with buprenorphine: clinical practices and barriers

P304

128-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1370/AFM.1595

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260683680

http://www.w3.org/2001/XMLSchema#string

P698

24615308

http://www.w3.org/2001/XMLSchema#string

P932

3948759

http://www.w3.org/2001/XMLSchema#string